CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Sexl, Veronika; Kollmann, Karoline

Abstrakt

Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are frequently deregulated in cancer and signify vulnerable nodes and potential therapeutic targets. We here focus on the cell cycle kinase CDK6 and on the MAPK pathway and on their interplay. We also provide an overview on clinical studies examining the effects of combinational treatments currently explored for several cancer types.

Dokumententyp

Übersichtsarbeit

Open Access Type

Gold

WoS ID

WOS:000602363300001

Projekt

ERC ADG: CDK6 in Transkription –vom Feind zum Freund